Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol)

Transfusion

Volumn 49, Issue 2, 2009, Pages 214-218

  Azuma, Hiroshi ^a   Hirayama, Junichi ^a   Akino, Mitsuaki ^a   Miura, Reiko ^a   Kiyama, Yoshio ^a   Imai, Kiyotoshi ^a   Kasai, Masaharu ^a   Koizumi, Kazuki ^a   Kakinoki, Yasutaka ^a   Makiguchi, Yusuke ^a   Kubo, Koji ^a   Atsuta, Yoshiko ^a   Fujihara, Mitsuhiro ^a   Homma, Chihiro ^a   Yamamoto, Sadamitsu ^a   Kato, Toshiaki ^a   Ikeda, Hisami ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

M SOL; PRESERVATION SOLUTION; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EDEMA; HEART PALPITATION; HUMAN; HYPOTENSION; PALLOR; PLASMA; RASH; RESPIRATORY DISTRESS; SUPERNATANT; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; URTICARIA; VOMITING;

BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; HYPERSENSITIVITY; ISOTONIC SOLUTIONS; ORGAN PRESERVATION SOLUTIONS; PLASMA; PLATELET COUNT; PLATELET TRANSFUSION; TIME FACTORS; TREATMENT OUTCOME;

EID: 58849128805     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01918.x     Document Type: Article

References (12)

1. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased tumor necrosis factor a (TNF-alpha) interleukin 1 and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF-alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993 33 : 195 9.
2. Heddle NM, Klama L, Singer J, Richars C, Fedak P, Walker I, Kelton JG. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994 331 : 625 8.
3. Muylle L. The role of cytokines in blood transfusion reactions. Blood Rev 1995 9 : 77 83.
4. Novotny VM, Van Doorn R, Witvliet MD, Claas FH, Brand A. Occurrence of allogeneic HLA and non HLA antibodies after transfusion of prestorage filtered platelets and red cells: a prospective study. Blood 1995 85 : 1736 41.
5. Vo TD, Cowles J, Heal JM, Blumberg N. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med 2001 11 : 45 7.
6. Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, Constantini LA, Patterson B, Roberts RS, Thorpe KE, Levine MN. A randomised controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002 42 : 556 66.
7. Hirayama J, Azuma H, Fujihara M, Homma C, Yamamoto S, Ikeda H. Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007 47 : 960 5.
8. Hirayama J, Azuma H, Fujihara M, Akino M, Homma C, Yamamoto S, Kato T, Ikeda H. Storage of platelets in 30% plasma and 70% M-sol additive solution. Transfusion 2008 27 : 567 8.
9. Buck SA, Kickler TS, McGuire M, Braine HG, Ness PM. The utility of platelet washing using an automated procedure for severe platelet allergic reactions. Transfusion 1987 27 : 391 3.
10. Ringwald J, Duerler T, Frankow O, Zimmermann R, Zingsem J, Strasser E, Antoon M, Eckstein R. Collection of hyperconcentrated platelets with Trima Accel. Vox Sang 2006 90 : 92 6.
11. De Wildt-Eggen J, Nauta S, Schrijver JG, Van Marwij Kooy M, Bins M, Van Prooijen HC. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000 40 : 398 403.
12. Kerkhoffs JL, Eikenboom JC, Schipperus MS, Van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, De Vries RR, Barge R, Van Rhenen DJ, Brand A. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006 108 : 3210 5.